UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Advanced practice nursing in France: Social capital assessment

Journal of the American Association of Nurse Practitioners, 2023-09, Vol.35 (9), p.528-530

2023

Volltextzugriff (PDF)

Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases

Annals of oncology, 2006-07, Vol.17 (7), p.1072-1082

2006

Volltextzugriff (PDF)

Detecting high-emitting methane sources in oil/gas fields using satellite observations

Atmospheric chemistry and physics, 2018-11, Vol.18 (23), p.16885-16896

2018

Volltextzugriff (PDF)

Assessing the capability of different satellite observing configurations to resolve the distribution of methane emissions at kilometer scales

Atmospheric chemistry and physics, 2018-06, Vol.18 (11), p.8265-8278

2018

Volltextzugriff (PDF)

Gonadotropin-Releasing Hormone Agonists and Fracture Risk: A Claims-Based Cohort Study of Men With Nonmetastatic Prostate Cancer

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7897-7903

2005

Volltextzugriff (PDF)

Responsiveness of the Acne-Specific Quality of Life Questionnaire (Acne-QoL) to Treatment for Acne Vulgaris in Placebo-Controlled Clinical Trials

Quality of life research, 2002-12, Vol.11 (8), p.809-816

2002

Volltextzugriff (PDF)

Risk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer

The Journal of urology, 2006, Vol.175 (1), p.136-139

2006

Volltextzugriff (PDF)

Evaluating minimal clinically important differences for the Acne-Specific Quality of Life Questionnaire

PharmacoEconomics, 2003-01, Vol.21 (15), p.1069-1079

2003

Volltextzugriff (PDF)

The Cost of Treatment of Skeletal-Related Events in Patients with Bone Metastases from Lung Cancer

Oncology, 2004-01, Vol.67 (5-6), p.390-396

2004

Volltextzugriff (PDF)

Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice

The Journal of supportive oncology, 2006-07, Vol.4 (7), p.341-347

2006

Volltextzugriff (PDF)

Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy

Cancer, 2004-08, Vol.101 (3), p.541-549

2004

Volltextzugriff (PDF)

Somatic Hypermutation and Junctional Diversification at Ig Heavy Chain Loci in the Nurse Shark

Journal of Immunology, 2005-12, Vol.175 (12), p.8105-8115

2005

Volltextzugriff (PDF)

Economic value of zoledronic acid compared with placebo in the treatment of skeletal metastases in patients with solid tumors: The case of the United Kingdom (UK)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.6603-6603

2007

Volltextzugriff (PDF)

Economic value of zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer: The case of the United Kingdom (UK)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.6617-6617

2007

Volltextzugriff (PDF)

Persistency with oral bisphosphonates in cancer patients

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.8221-8221

2005

Volltextzugriff (PDF)

Effects of skeletal complications on total medical care costs in patients with bone metastases of solid tumors

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.8094-8094

2005

Volltextzugriff (PDF)

Cost effectiveness of intravenous (IV) zoledronic acid vs other IV bisphosphonates for the prevention of bone complications in breast cancer patients with bone metastases: A Markov model from the UK perspective

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.721-721

2005

Volltextzugriff (PDF)

A Markov model to evaluate the cost effectiveness of intravenous (IV) zoledronic acid vs IV generic pamidronate or oral ibandronate in the prevention of bone complications in breast cancer patients with bone metastases

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.664-664

2005

Volltextzugriff (PDF)

PMW4 DEVELOPING A BETTER UNDERSTANDING OF COST-EFFECTIVENESS OF HORMONE REPLACEMENT THERAPY (HRT): A COMPREHENSIVE REVIEW OF ECONOMIC ANALYSIS FROM 1980 TO 2001

Value in health, 2002-05, Vol.5 (3), p.267-267

2002

Volltextzugriff (PDF)

O-061 Frequency and costs of multiple skeletal complications inpatients with bone metastases of lung cancer

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S23-S24

2005

Volltextzugriff (PDF)

Effect of zoledronic acid on clinically meaningful changes in pain associated with metastatic prostate cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4680-4680

2004

Volltextzugriff (PDF)

Effect of zoledronic acid on clinically meaningful changes in pain associated with metastatic prostate cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.4680-4680

2004

Volltextzugriff (PDF)

Risk factors for clinical fractures among men with non-metastatic prostate cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4560-4560

2005

Volltextzugriff (PDF)

Risk of osteoporosis/osteopenia among women with breast cancer receiving anti-cancer therapy (ACT)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.665-665

2005

Volltextzugriff (PDF)

Cost-effectiveness of extended adjuvant letrozole after five years of tamoxifen in postmenopausal early breast cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6044-6044

2004

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Englisch
(117)

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Life Sciences & Biomedicine
(52)
Humans
(44)
Female
(29)
Male
(28)
Middle Aged
(25)
Adult
(21)
Aged
(16)
Gastroenterology & Hepatology
(13)
General & Internal Medicine
(11)
Biological And Medical Sciences
(10)
Medicine, General & Internal
(10)
Medical Sciences
(9)
Biopsy
(8)
Fibrosis
(8)
Liver Diseases
(8)
Adolescent
(7)
Non-Alcoholic Fatty Liver Disease - Pathology
(7)
Oncology
(7)
Treatment Outcome
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Advanced practice nursing in France: Social capital assessment

Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases

Detecting high-emitting methane sources in oil/gas fields using satellite observations

Assessing the capability of different satellite observing configurations to resolve the distribution of methane emissions at kilometer scales

Gonadotropin-Releasing Hormone Agonists and Fracture Risk: A Claims-Based Cohort Study of Men With Nonmetastatic Prostate Cancer

Responsiveness of the Acne-Specific Quality of Life Questionnaire (Acne-QoL) to Treatment for Acne Vulgaris in Placebo-Controlled Clinical Trials

Risk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer

Evaluating minimal clinically important differences for the Acne-Specific Quality of Life Questionnaire

The Cost of Treatment of Skeletal-Related Events in Patients with Bone Metastases from Lung Cancer

Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice

Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy

Somatic Hypermutation and Junctional Diversification at Ig Heavy Chain Loci in the Nurse Shark

Economic value of zoledronic acid compared with placebo in the treatment of skeletal metastases in patients with solid tumors: The case of the United Kingdom (UK)

Economic value of zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer: The case of the United Kingdom (UK)

Persistency with oral bisphosphonates in cancer patients

Effects of skeletal complications on total medical care costs in patients with bone metastases of solid tumors

Cost effectiveness of intravenous (IV) zoledronic acid vs other IV bisphosphonates for the prevention of bone complications in breast cancer patients with bone metastases: A Markov model from the UK perspective

A Markov model to evaluate the cost effectiveness of intravenous (IV) zoledronic acid vs IV generic pamidronate or oral ibandronate in the prevention of bone complications in breast cancer patients with bone metastases

PMW4 DEVELOPING A BETTER UNDERSTANDING OF COST-EFFECTIVENESS OF HORMONE REPLACEMENT THERAPY (HRT): A COMPREHENSIVE REVIEW OF ECONOMIC ANALYSIS FROM 1980 TO 2001

O-061 Frequency and costs of multiple skeletal complications inpatients with bone metastases of lung cancer

Effect of zoledronic acid on clinically meaningful changes in pain associated with metastatic prostate cancer

Effect of zoledronic acid on clinically meaningful changes in pain associated with metastatic prostate cancer

Risk factors for clinical fractures among men with non-metastatic prostate cancer

Risk of osteoporosis/osteopenia among women with breast cancer receiving anti-cancer therapy (ACT)

Cost-effectiveness of extended adjuvant letrozole after five years of tamoxifen in postmenopausal early breast cancer

Suchergebnisse filtern